Report of a Large Cohort of Intermediate-Risk Prostate Cancer Patients Treated with Cs-131 Brachytherapy
نویسندگان
چکیده
منابع مشابه
Stratification of brachytherapy-treated intermediate-risk prostate cancer patients into favorable and unfavorable cohorts
PURPOSE To evaluate biochemical failure (BF) and prostate cancer specific mortality (PCSM) in intermediate-risk (IR) brachytherapy patients stratified into favorable and unfavorable cohorts, and to compare those outcomes to patients with low (LR) and high-risk (HR) disease. MATERIAL AND METHODS From March 1995 till February 2012, 2,502 consecutive patients underwent permanent interstitial bra...
متن کاملLow-dose rate brachytherapy for patients with low- or intermediate-risk prostate cancer: A systematic review.
INTRODUCTION We review the current evidence for the role of low-dose rate brachytherapy (PB) in patients with low- or intermediate-risk prostate cancer using a systematic review of the literature. METHODS We searched MEDLINE and EMBASE (from January 1996 to October 2011), the Cochrane Library, relevant guideline web-sites, and websites for meetings specific for genitourinary diseases. RESUL...
متن کاملAndrogen Deprivation in Prostate Cancer Patients Treated with Brachytherapy
This article is addressing the role of androgen deprivation therapy (ADT) in prostate brachytherapy. No randomized trials to date evaluating the efficacy of hormonal therapy combined with brachytherapy. Many retrospective trials assessed the role of neoadjuvant androgen deprivation and interstitial permanent prostate brachytherapy in an effort to shrink the prostate gland and to facilitate the ...
متن کاملthe study of aaag repeat polymorphism in promoter of errg gene and its association with the risk of breast cancer in isfahan region
چکیده: سرطان پستان دومین عامل مرگ مرتبط با سرطان در خانم ها است. از آنجا که سرطان پستان یک تومور وابسته به هورمون است، می تواند توسط وضعیت هورمون های استروئیدی شامل استروژن و پروژسترون تنظیم شود. استروژن نقش مهمی در توسعه و پیشرفت سرطان پستان ایفا می کند و تاثیر خود را روی بیان ژن های هدف از طریق گیرنده های استروژن اعمال می کند. اما گروه دیگری از گیرنده های هسته ای به نام گیرنده های مرتبط به ا...
15 صفحه اولCesium 131 versus iodine 125 implants for prostate cancer: evaluation of early PSA response.
INTRODUCTION Given the shorter half-life of cesium-131 (Cs-131) compared to iodine-125 (I-125), we hypothesized that initial PSA outcomes may differ. We compare initial PSA outcomes in men undergoing Cs-131 prostate brachytherapy to men treated with I-125. PATIENTS AND METHODS The first post-treatment PSA (obtained 3-6 months after the procedure) was compared in patients undergoing I-125 pros...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: International Journal of Radiation Oncology*Biology*Physics
سال: 2020
ISSN: 0360-3016
DOI: 10.1016/j.ijrobp.2020.07.576